Need a specific person's email?
Browse Triangulum Biopharma's employee directory (about 2 employees) and reveal verified emails free.
Triangulum Biopharma's most common email format is First@tbp-cro.com (ex. John@tbp-cro.com), used for 100% of tbp-cro.com addresses. Triangulum Biopharma uses 1 email pattern.
| Format | Example | Share of tbp-cro.com |
|---|---|---|
| First@tbp-cro.comMost common | John@tbp-cro.com |
Browse Triangulum Biopharma's employee directory (about 2 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States2-10 Employees
Triangulum Biopharma is a biotechnology research company based in Carlsbad, California, focused on providing pre-clinical pharmacology services to scientists in the biopharma industry. With a mission to support drug development, the firm emphasizes a customer-centric approach and leverages experience across small molecules, biologics, and RNA-based therapeutics to help move modern medicines toward patients more efficiently. The organization operates from San Diego, California, and is led by a team whose collective expertise spans more than six decades, underscored by substantial scientific output and contributions to the field. Targeting researchers and developers in biopharma, Triangulum Biopharma aims to facilitate early-stage pharmacology work, offering depth and breadth of experience to accelerate pre-clinical programs. The company situates itself within the biotechnology research sector as a specialized provider of pre-clinical pharmacology services, drawing on a history of collaborators and prior work that has informed later-stage clinical development. A recent development notes ongoing operation from its California base, reflecting its focus on enabling scientists to advance drug candidates through early testing stages.
Most common format
First@tbp-cro.com
Example: John@tbp-cro.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.